This inventor holds 1 USPTO granted patent. Top assignee: Albert Einstein College of Medicine. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: David J. Lefer: Innovator in Myocardial Injury Treatment
Introduction
David J. Lefer is a notable inventor based in Decatur, GA (US). He has made significant contributions to the field of medicine, particularly in the treatment of myocardial injury. His innovative approach focuses on the use of humanin and its analogs to address various health issues.
Latest Patents
David J. Lefer holds a patent for the "Treatment of myocardial injury with humanin analogs." This patent outlines methods for using humanin and its analogs to treat mammals exhibiting or at risk for insulin resistance. It also aims to increase insulin sensitivity, treat type-2 diabetes mellitus, metabolic syndrome, neurodegeneration, and prevent myocardial injury while determining longevity.
Career Highlights
David J. Lefer is affiliated with the Albert Einstein College of Medicine, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating serious health conditions.
Collaborations
David collaborates with Radhika Muzumdar, enhancing the research efforts in their field. Their partnership exemplifies the importance of teamwork in scientific advancements.
Conclusion
David J. Lefer's contributions to medical science through his innovative patent demonstrate his commitment to improving health outcomes. His work in treating myocardial injury is a testament to the potential of scientific research in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
